Construction of secretory eukaryotic expression vector of NT4-APOPTIN-HA2-TAT and its effects on tumor cells
Jiansheng Wang, Mingxin Zhang, Xiaoyi Duan, Liu De-chun, Guangxiao Yang, Quanying Wang
Abstract
Jiansheng Wang, Mingxin Zhang, Xiaoyi Duan, Liu De-chun, Guangxiao Yang, Quanying Wang
Abstract
C288 Objective :To enhance apoptin’s antitumor therapeutic effect , the Apoptin gene was fused with NT4 and HA2-TAT to construct secretory eukaryotic expression vector,and explore its antitumor effect. Methods : The Apoptin gene were obtained by T-vector method,and then Apoptin and HA2-TAT gene were inserted in pUC19/NT4 vector. The fusion gene of NT4-Apoptin-HA2-TAT was sub-cloned into the shuttle plasmid of adeno-associated virus; the products were co-transferred into HEK-293 cell line with helper plasmid pAAV/Ad and adeno plasmid pFG140.The recombinant adeno-associated virus was produced by homologous recombination of above 3 plasmids in HEK-293 cells and its titer was measured by quantitative dot blot hybridization. The effects of AAV-NT4-Apoptin -HA2-TAT on human HepG2 cell line and mouse fibroblast cell NIH3T3 were measured by MTT assay and Flow cytometry assay. Results: The vector was confirmed by restriction enzyme digestion and DNA sequencing. High titer of recombinant adeno-associated virus was obtained by homologous recombination in HEK-293 cells(3.14×1011pfu/ml). It could induce apoptosis after HepG2 cells were transfected in 48h later, but not in normal NIH3T3 cells, which significantly decreased the survival rate of HepG2 cells. Conclusion: The secretory recombinant adeno-associated virus vector encoding gene NT4-Apoptin-HA2-TAT has been successfully constructed in this experiment by molecular cloning and in vitro recombination techniques,which can be secreted and induces apoptosis of tumor cells specificity, laying a foundation for further research of gene therapy of cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
C288 Objective :To enhance apoptin’s antitumor therapeutic effect , the Apoptin gene was fused with NT4 and HA2-TAT to construct secretory eukaryotic expression vector,and explore its antitumor effect. Methods : The Apoptin gene were obtained by T-vector method,and then Apoptin and HA2-TAT gene were inserted in pUC19/NT4 vector. The fusion gene of NT4-Apoptin-HA2-TAT was sub-cloned into the shuttle plasmid of adeno-associated virus; the products were co-transferred into HEK-293 cell line with helper plasmid pAAV/Ad and adeno plasmid pFG140.The recombinant adeno-associated virus was produced by homologous recombination of above 3 plasmids in HEK-293 cells and its titer was measured by quantitative dot blot hybridization. The effects of AAV-NT4-Apoptin -HA2-TAT on human HepG2 cell line and mouse fibroblast cell NIH3T3 were measured by MTT assay and Flow cytometry assay. Results: The vector was confirmed by restriction enzyme digestion and DNA sequencing. High titer of recombinant adeno-associated virus was obtained by homologous recombination in HEK-293 cells(3.14×1011pfu/ml). It could induce apoptosis after HepG2 cells were transfected in 48h later, but not in normal NIH3T3 cells, which significantly decreased the survival rate of HepG2 cells. Conclusion: The secretory recombinant adeno-associated virus vector encoding gene NT4-Apoptin-HA2-TAT has been successfully constructed in this experiment by molecular cloning and in vitro recombination techniques,which can be secreted and induces apoptosis of tumor cells specificity, laying a foundation for further research of gene therapy of cancer.
Key concepts: Molecular biology, Homologous recombination, Transfection, Biology, HEK 293 cells, Recombinant DNA, Plasmid, Viral vector